Valsartan Bellwether Lawsuit Over Cancer Caused by Recalled Blood Pressure Drug Set for September 8, 2025
Parties will meet with the MDL judge today, to discuss issues scheduling the remaining bellwether trials selected by the Court.
Tag Archives: NDMA
-
-
Zantac Bladder Cancer Lawsuit Trial Ends With Hung Jury in California
California jury agreed that Boehringer Ingelheim's heartburn drug was dangerous, but was split on whether Zantac caused the bladder cancer diagnosis.
-
Valsartan Liver Cancer Lawsuit Selected for First Jury Trial in MDL
First bellwether trial in the valsartan MDL will involve claims brought by an Alabama man diagnosed with liver cancer, which is the most commonly reported injury caused by the recalled blood pressure drug.
-
Valsartan Cancer Lawsuits To Be Set for First Bellwether Trial, Instead of Third-Party Payor Claim
More than 1,270 Valsartan lawsuits are currently awaiting trial, most involving plaintiffs diagnosed with cancer following exposure to the recalled blood pressure drug, who are getting sicker and many are dying.
-
GSK To Pay $2.2 Billion To Settle Zantac Cancer Lawsuits Brought by 80,000 Consumers
Zantac settlement must still be approved by individual plaintiffs, but is expected to resolve vast majority of cancer lawsuits filed in state courts.
-
FDA Finalizes Guidelines To Keep Cancerous Impurities Out of U.S. Medications
Nitrosamine contamination has resulted in massive recalls for valsartan, Zantac and other medications, as well as lawsuits by users who developed cancer.
-
Delaware Zantac Lawsuits Continue To Be Filed As GlaxoSmithKline Appeals to State Supreme Court
Drug maker is challenging a lower court ruling, which allows Zantac lawsuits in Delaware to move forward to trial over the increased risk of cancer caused by the recalled heartburn medication.
-
GSK Gets Expert Witness Excluded in Zantac Cancer Lawsuit in Florida Before Trial
Florida ruling does not directly impact other Zantac lawsuits filed against GlaxoSmithKline in other state courts, each involving claims that former users were not adequately warned about the cancer risks that led to a 2020 recall.
-
Jury Rejects Claim That Zantac Caused Colorectal Cancer Diagnosis of Illinois Woman
Defense verdict comes as GSK faces several additional Zantac trials in Florida, Pennsylvania and Nevada in the coming months, each raising similar allegations that the recalled heartburn drug caused cancer to develop in former users.
-
GSK Continues To Settle Zantac Lawsuits Before Trial, While Maintaining Heartburn Drug Did Not Cause Cancers
Despite agreeing to a number of individual Zantac lawsuit settlements and issuing a massive Zantac recall in 2020, GSK continues to argue that there is no evidence the recalled heartburn drug caused cancers among users.
